These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26513076)

  • 1. Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
    Painsi C; Patscheider M; Inzinger M; Lange-Asschenfeldt B; Quehenberger F; Wolf P
    J Dtsch Dermatol Ges; 2015 Nov; 13(11):1156-63. PubMed ID: 26513076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
    de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
    Dermatology; 2010; 220(4):329-32. PubMed ID: 20389024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
    Painsi C; Patscheider M; Inzinger M; Huegel R; Lange-Asschenfeldt B; Quehenberger F; Wolf P
    Br J Dermatol; 2015 Sep; 173(3):815-7. PubMed ID: 25704591
    [No Abstract]   [Full Text] [Related]  

  • 6. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
    Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
    Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD; Voss M
    Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
    Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
    J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of the inpatient treatment of psoriasis with dithranol.
    De Bersaques J
    Dermatologica; 1987; 175(2):64-8. PubMed ID: 3308543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
    Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted 307 nm UVB-excimer light vs. topical dithranol in psoriasis.
    Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):122-3. PubMed ID: 21251088
    [No Abstract]   [Full Text] [Related]  

  • 17. Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp.
    Wulff-Woesten A; Ohlendorf D; Henz BM; Haas N
    Skin Pharmacol Physiol; 2004; 17(2):91-7. PubMed ID: 14976386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries.
    Ragnarson Tennvall G; Hjortsberg C; Bjarnason A; Gniadecki R; Heikkilä H; Jemec GB; Kragballe K; Miller IM; Svensson Å
    Acta Derm Venereol; 2013 Jul; 93(4):442-5. PubMed ID: 23138500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.